www.fdanews.com/articles/142481-lannett-receives-fda-approval-for-triamterene-with-hydrochlorothiazide-37-5-25mg-capsules
Lannett Receives FDA Approval for Triamterene With Hydrochlorothiazide 37.5/25mg Capsules
December 13, 2011
Lannett Company has received approval from the FDA of its abbreviated new drug application for triamterene with hydrochlorothiazide 37.5/25mg capsules.
The Street
The Street